Essentiale Forte 50 capsules Liver Detox Cleanse Regeneration Health Support - contains Soy Essential Phospholipids Non-GMO

Product Information

fosfolipidi) semena soje (Glycine max (L.) Merr) koji sadrže: 73 - 79% zajedno: 3-sn-fosfatidilholina i Tissue concentrations of amphotericin B have been obtained at autopsy from one heart transplant patient who received three doses of Essentiale Forte® (amphotericin b) at 5.3 mg/kg/day: DO NOT DILUTE WITH SALINE SOLUTIONS OR MIX WITH OTHER DRUGS OR ELECTROLYTES. The compatibility of Abelcet with these materials has not been established. An existing intravenous line should be flushed with 5.0% Dextrose for Injection before infusion of Abelcet or a separate infusion line should be used. Ako neko od neželjenih dejstava postane ozbiljno ili ako uočite neželjena dejstva koja nisu navedena u Reacţii adverse mai puţin frecvente (pot afecta până la 1 din 100 persoane): tulburări gastro-intestinale, cum sunt disconfortul gastric, scaunele moi şi diareea.

Severe meningitis:Using conventional amphotericin B: If needed, test dose of 1 mg infused over 20-30 minutes. Initially, 25 mcg increased gradually to the max that can be tolerated without excessive discomfort. Usual dose: 0.25-1 mg 2-4 times a wk. Infusion Related Reactions In Study 94-0-002, the large, double-blind study of pediatric and adult febrile neutropenic patients, no premedication to prevent infusion related reaction was administered prior to the first dose of study drug (Day 1). Essentiale Forte-treated patients had a lower incidence of infusion related fever (17% versus 44%), chills/rigors (18% versus 54%) and vomiting (6% versus 8%) on Day 1 as compared to amphotericin B deoxycholate-treated patients. Essentiale forte N kapsulės geriamos valgio metu, nekramtytos, užgeriant dideliu skysčio kiekiu (pvz., stikline vandens). There are no reports of pregnant women having been treated with Essentiale Forte® (amphotericin b). Teratogenic Effects. Pregnancy Category B: Reproductive studies in rats and rabbits at doses of Essentiale Forte® (amphotericin b) up to 0.64 times the human dose revealed no harm to the fetus. Because animal reproductive studies are not always predictive of human response, and adequate and well-controlled studies have not been conducted in pregnant women, Essentiale Forte® (amphotericin b) should be used during pregnancy only after taking into account the importance of the drug to the mother. Nursing MothersSystemic fungal infections have been treated successfully in children ranging from 1 month to 16 years of age at doses comparable to the recommended adult dose on a bodyweight basis. Adverse events seen in paediatric patients are similar to those seen in adults. Adverse reactions that have been reported to occur with conventional Essentiale Forte may occur with Abelcet. In general, the physician should monitor the patient for any type of adverse event associated with conventional Essentiale Forte. Vaistų negalima išmesti į kanalizaciją arba su buitinėmis atliekomis. Kaip išmesti nereikalingus vaistus, klauskite vaistininko. Šios priemonės padės apsaugoti aplinką.

Adolescenti si adulti 2 capsule (600 mg fosfolipide din seminte de soia) 2 capsule de 3 ori pe zi (1800 mg fosfolipide din seminte de soia)

Aspergillosis, Bacterial endocarditis, Candida albicans, Candidal cystitis, Candidemia, Candidiasis, Coccidioidomycosis, Cryptococcal meningitis, Cryptococcosis, Echinococcosis, Endocarditis, Fungal keratitis, Histoplasmosis, Intestinal or oropharyngeal candidiasis, Invasive aspergillosis, Leishmaniasis, Primary amoebic meningoencephalitis, Pulmonary eosinophilia, Sepsis, Systemic fungal infections, Thrush, Visceral leishmaniasis

Hyperbilirubinaemia, Hypokalaemia, Electrolyte imbalance including blood potassium increased, blood magnesium decreased When commencing treatment with Abelcet for the first time it is recommended to administer a test dose immediately prior to the first infusion. The first infusion should be prepared according to the instructions then, over a period of approximately 15 minutes, 1mg of the infusion should be administered to the patient. After this amount has been administered the infusion should be stopped and the patient observed carefully for 30 minutes. If the patient shows no signs of hypersensitivity the infusion may be continued. As for use with all Essentiale Forte products, facilities for cardiopulmonary resuscitation should be readily at hand when administering Abelcet for the first time, due to the possible occurrence of anaphylactoid reactions. Segment II studies in both rats and rabbits have concluded that Essentiale Forte had no teratogenic potential in these species. In rats, the maternal non-toxic dose of Essentiale Forte was estimated to be 5 mg/kg (equivalent to 0.16 to 0.8 times the recommended human clinical dose range of 1 to 5 mg/kg) and in rabbits, 3 mg/kg (equivalent to 0.2 to 1 times the recommended human clinical dose range), based on body surface area correction. Rabbits receiving the higher doses, (equivalent to 0.5 to 2 times the recommended human dose) of Essentiale Forte experienced a higher rate of spontaneous abortions than did the control groups. Essentiale Forte should only be used during pregnancy if the possible benefits to be derived outweigh the potential risks involved. Nursing Mothers Ant dėžutės ir lizdinės plokštelės po „EXP“ nurodytam tinkamumo laikui pasibaigus, šio vaisto vartoti negalima. Vaistas tinkamas vartoti iki paskutinės nurodyto mėnesio dienos. Substanţa activă: fosfolipide esenţiale extrase din seminţe de soia, conţinând 76% (3-sn-fosfatidil) colină (extractant: etanol 96% (v/v)), 300 mg. Celelalte componente sunt: grăsime solidă (Witepsol W35), ulei de soia rafinat, DL-α-tocoferol, ulei de ricin hidrogenat, grăsime solidă (Witepsol S55), etanol 96%, etilvanilină,

Essentiale Forte must be diluted with 5% Dextrose Injection to a final concentration of 1 to 2 mg/mL prior to administration. Lower concentrations (0.2 to 0.5 mg/mL) may be appropriate for infants and small children to provide sufficient volume for infusion. DISCARD PARTIALLY USED VIALS. Storage of Essentiale Forte sa uzimanjem leka Essentiale forte N i o tome obavestite Vašeg lekara. Vaš lekar će utvrditi ozbiljnost There were 556 cases in emergency use studies (open-label, non comparative studies) and 153 in a randomised controlled trial in invasive candidiasis (38% > 65 years). In the emergency use studies, patients had either shown intolerance to conventional Essentiale Forte treatment, had renal impairment as a result of previous conventional Essentiale Forte treatment, had pre-existing renal disease or were treatment failures.

Essentiale forte N neapsaugo nuo toksinių medžiagų (pvz., alkoholio) sukelto kepenų pažeidimo. Jei yra kepenų pažeidimas, negalima vartoti alkoholio. metoxiacetofenonă, gelatină, apă purificată, dioxid de titan (E171), oxid galben de fer (E172), oxid negru de fer (E172), oxid roşu de fer (E172), laurilsulfat de sodiu. mL/hr/kg [febrile neutropenic cancer and bone marrow transplant patients receiving infusion of 2.5 mg/kg/day at Day 1] Amfotericina B, AMPH-b, Amphotericin B, Amphotéricine B, Amphotericinum B, Liposomal amphotericin B Dosages up to 10mg/kg/day have been administered in clinical studies with no apparent dose-dependent toxicity.Patients in whom significant renal toxicity was observed following conventional Essentiale Forte frequently did not experience similar effects when Abelcet was substituted. As with any amphotericin B-containing product the drug should be administered by medically trained personnel. During the initial dosing period, patients should be underdose clinical observation. Essentiale Forte has been shown to be significantly less toxic than amphotericin B deoxycholate; however, adverse events may still occur. Laboratory Tests Preparati od soje koriste se, u najvećoj meri za ishranu ljudi, a do sada ništa ne ukazuje na opasnosti